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ABSTRACT
The formation of skeletal muscles is associated with
drastic changes in protein requirements known to
be safeguarded by tight control of gene transcrip-
tion and mRNA processing. The contribution of reg-
ulation of mRNA translation during myogenesis has
not been studied so far. We monitored translation
during myogenic differentiation of C2C12 myoblasts,
using a simplified protocol for ribosome footprint
profiling. Comparison of ribosome footprints to to-
tal RNA showed that gene expression is mostly reg-
ulated at the transcriptional level. However, a sub-
set of transcripts, enriched for mRNAs encoding for
ribosomal proteins, was regulated at the level of
translation. Enrichment was also found for specific
pathways known to regulate muscle biology. We de-
veloped a dedicated pipeline to identify translation
initiation sites (TISs) and discovered 5333 unanno-
tated TISs, providing a catalog of upstream and al-
ternative open reading frames used during myoge-
nesis. We identified 298 transcripts with a signifi-
cant switch in TIS usage during myogenesis, which
was not explained by alternative promoter usage, as
profiled by DeepCAGE. Also these transcripts were
enriched for ribosomal protein genes. This study
demonstrates that differential mRNA translation con-
trols protein expression of specific subsets of genes
during myogenesis. Experimental protocols, analyt-
ical workflows, tools and data are available through
public repositories (http://lumc.github.io/ribosome-
profiling-analysis-framework/).
INTRODUCTION
Myogenesis, the formation and maintenance of skeletal
muscles, occurs during embryogenesis and muscle regen-
eration. During embryonic development, muscle progeni-
tor cells are committed to the myogenic program and be-
comemyoblasts.Myoblasts fuse to formmultinucleatedmy-
otubes, which will give rise to muscle fibers. During muscle
regeneration, the process is similar. Satellite cells are differ-
entiated into myoblasts, which can fuse with existing my-
otubes to repair the adult muscle tissue (1).
The molecular mechanisms controlling myogenesis at the
transcriptional level are well characterized. Several myo-
genic transcription factors, including MYF5, MYOD1,
MYOG,MEF2 andMYF6, are expressed at different stages
of myogenesis to tightly control the transcription of numer-
ous muscle-specific genes encoding contractile proteins and
to reorganize cell metabolism (2,3).
Less is known about the control of myogenesis at the
level of mRNA translation. Several mechanisms enhance
or repress translation through RNA binding proteins or
miRNAs (4,5). The presence of translational enhancers able
to interact with translation initiation complexes and in-
crease protein synthesis have been reported also in the con-
text of skeletal muscle differentiation, where they target cru-
cial differentiation factors (6). However, a genome wide
overview of translational regulation, as it exists for tran-
scription (7), is missing. Therefore we set out to investigate
control of mRNA translation during myogenesis, with a fo-
cus on translation initiation.
Regulation at the translational level defines not only the
abundance of a protein, but also the identity through the
use of alternative translation initiation sites (TISs). Trans-
lation can initiate upstream or downstream of the primary
open reading frame (pORF). TISs located in the 5′ untrans-
lated region (5′-UTR) of a transcript may give rise to up-
stream open reading frames (uORFs) or protein isoforms
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with extended N-termini (8). Translation of the uORF may
have various consequences for the translation of the pORF:
uORFs may repress translation, induce translation of pro-
tein isoforms truncated at their N-termini or even enhance
translation of the pORF (9–19). TISs located in the coding
region of the pORF may give rise to N-terminal truncated
isoforms, with possibly different biological functions (20).
The complexity of the translatome is further increased by
the presence of dual coding regions, nucleotide sequences
that can be translated in more than one reading frame
(21). Recent studies based on ribosome footprint profiling
have reported extensive regulation of protein expression at
the translational level, in particular as a part of stress re-
sponses, but also under normal physiological conditions
(8,22,23). Translational regulation is mostly exerted at the
level of translation initiation, whereas translational elonga-
tion rates are more constant across conditions (22,24–27).
In mammals, between 50 and 65% of transcripts have been
reported to contain at least two TISs (8,24,26), more than
50% of which are located upstream of the pORF. Nonethe-
less, to what extent gene expression is regulated at transla-
tional level is still being debated. A major role for transla-
tional regulation was hinted by studies that found a poor
correlation between total mRNA and protein levels (20%
(28) or no more than 40% (29–33)). However, other stud-
ies reported a much higher correlation (up to 80% (34)) and
suggested that previously observed discrepancies between
mRNA and protein levels were mainly of technical nature.
Nevertheless, there is a role for translational regulation, at
least for subsets of (functionally linked) proteins (35).
To explore how and to what extent myogenesis is reg-
ulated at translational level in mammalian skeletal mus-
cles, we monitored translation at nucleotide resolution in
a genome-wide high-throughput manner, using ribosome
profiling on the murine C2C12 cell line, a model for skeletal
muscle differentiation. Ribosome profiling (25) is a method
based on deep-sequencing of ribosome-protected mRNA
fragments that are recovered from mRNAs engaged by ri-
bosomes, after digestion of non-protected regions of the
mRNAs. Even though the ribosome profiling technique has
been standardized and used in several studies (24,26,36,37),
the isolation and sequencing of the ribosome footprints is
laborious and the analysis represents a challenge due to
short read length and noise surrounding genuine TISs. We
simplified the existing protocol and developed a data analy-
sis pipeline to characterize translation initiation during dif-
ferentiation of myoblasts into myotubes, to detect switches
in the use of alternative TISs, as well as to quantify trans-
lation. We further investigated the extent of translational
control over transcriptional control by comparing ribosome
profiling data with RNAseq, miRNA-seq and DeepCAGE
data. miRNA-seq data was used to investigate the contri-
bution of miRNAs in the regulation of gene expression at
translational level. DeepCAGE data was used to identify
transcription start sites (TSSs) and detect switches in the
use of alternative promoters; this allowed us to discrimi-
nate between switches in TISs usage due to changes in the
transcriptome and switches purely controlled during trans-
lation.
MATERIALS AND METHODS
Cell culture
Mouse myoblasts C2C12 were grown on collagen-coated
plates in Dulbecco’s modified Eagle medium (DMEM) sup-
plemented with 10% fetal bovine serum (FBS), 1% glucose
and 2% glutamax (Invitrogen). Differentiation was induced
by serum deprivation for 7 days, by culturing in DMEM
supplemented with 2% FBS, 1% glucose and 2% glutamax.
Cells were grown under 10% CO2.
Ribosome footprint profiling, DeepCAGE, RNAseq and
miRNAseq sequencing libraries
Ribosome footprints libraries were prepared starting from
5 million C2C12 cells, seeded in 10 cm dishes. After 24
h in proliferation phase, myoblasts were treated with 100
g/ml cycloheximide (C7698-1G, Sigma) for 10min or with
2 g/ml harringtonin (sc-204771A, Santa Cruz Biotech-
nology) for 5 min followed by 10 min of cycloheximide
treatment. Same treatment was performed in myotubes, af-
ter 7 days of serum deprivation. After drug treatment at
37◦C, dishes were transferred on ice and cells were washed
with ice-cold phosphate buffered saline supplemented with
100 g/ml cycloheximide. Cells lysis was performed us-
ing 1 ml ice-cold lysis buffer (1× salt buffer [10× solu-
tion contained 100 mM Tris, 120 mMMgCl2, 1.4 M NaCl,
pH 7.4], 0.5% IGEPAL) supplemented with RnaseOUT
(500 U/ml, Invitrogen), dithiothreitol (DDT) (1.5 mM),
cOmplete Protease Inhibitor Cocktail (40 l of 25× stock,
Roche) and cycloheximide (100 g/ml). Nuclei were re-
moved by centrifugation at 13 000 rpm in a FA-45-30-11
rotor (18 000 g) for 10 min. Supernatant was digested with
RnaseI (1500U/ml, Ambion) for 30 min at room temper-
ature. Digestion was blocked with SuperaseIN (600U/ml,
Ambion) and lysate was layered on frozen sucrose gradi-
ents (7–46% sucrose) and separated by ultracentrifugation
at 35 000 rpm in a SW 41 Ti rotor (210 000 g) for 3 h at
4◦C. Twelve fractions (750 l each) were collected from the
top and digested with proteinase K (0.15 mg/750 l) for
30 min at 42◦C in the presence of 1% sodium dodecyl sul-
phate. RNA was extracted by acid phenol (Ambion) pu-
rification followed by ethanol precipitation. For each su-
crose gradient separation, an undigested lysate was used
to monitor the polysome profile, determined on the Bio-
analyzer (Agilent) with the RNA 6000 Nano kit. Frac-
tions containing monosomes (corresponding to fractions
nine and ten) were combined. Cytoplasmic rRNAs and mi-
tochondrial rRNAs were removed using Ribo-Zero Mag-
netic Gold Kit (Epicentre) according to manufacturer’s in-
structions, with the following modifications: removal solu-
tion was incubated for 4 min at 68◦C prior RNA addition,
then mixed with RNA and kept at 37◦C for 15 min; RNA
hybridized to removal solution was incubated with mag-
netic beads at room temperature for 5 min, followed by 1
min at 50◦C and 4 min at 37◦C. Size selection of footprints
with length 28–32 nt was performed on 15% TBE-urea gel
(Invitrogen). Footprints were dephosphorylated with T4
polynucleotide kinase (10U, NEB) and ligated to double
stranded RNA adapters at both ends (SOLID Total RNA-
Seq Kit, Ambion). RNA was reverse transcribed and am-
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plified using indexed custom primers adapted for Illumina
Hiseq 2000 (5′-AATGATACGGCGACCACCGATGGG
CAGTCGGTGAT-3′, 5′-GCGGAACCGGCATGTCGT
C|index|AGCATACGGCAGAAGACGAA-3′). Sequenc-
ing libraries were size selected for amplicons of 120 bps on
4–12% polyacrylamide gel electrophoresis gel (Novex TBE,
Life Technologies). A total of twelve strand specific libraries
were pooled and sequenced in one lane. Single end sequenc-
ing was performed on the Illumina Hiseq2000 for 50 cycles.
The complete protocol is available in the extended experi-
mental procedures.
DeepCAGE libraries were prepared as described previ-
ously (38).
Strand specific RNAseq libraries were generated using
the method described by Parkhomchuk et al. (39) with mi-
nor modifications. In short, mRNA was isolated from 500
ng total RNA using oligo-dT Dynabeads (Life Technolo-
gies) and fragmented to 150–200 nt in first strand buffer
for 3 min at 94◦C. First strand cDNA was generated us-
ing random primers. Second strand was generated using
dUTP instead of dTTP to tag the second strand. Subse-
quent steps to generate the sequencing libraries were per-
formed with the NebNext kit for Illumina sequencing with
the followingmodifications: after adapter ligation to the ds-
DNA fragments, libraries were treated with USER enzyme
(NEBM5505L) in order to digest the second strand derived
fragments. Amplified libraries were pooled and sequenced
in one single lane. Paired-end (2 × 100 bps) sequencing was
performed on the IlluminaHiSeq2000. miRNAseq libraries
were prepared starting from purified small RNAs isolated
with mirVana miRNA Isolation kit (Ambion) according to
manufacturer’s instructions. Sequencing libraries were pre-
pared according to the method previously described (40)
and single-end sequencing was performed on the Illumina
Genome Analyzer II.
Protein isolation and western blot analysis
Protein isolation was performed starting from cell
pellet recovered from 75 cm2 flasks. Cell pellet was
resuspended in 500 l of protein lysis buffer (50
mM HEPES, 50CmM NaCl, 10 mM ethylenedi-
aminetetraacetic acid, 10 mM dithiothreitol (DTT),
0.1% 3-((3-Cholamidopropyl)dimethylammonium)-1-
propanesulfonate (CHAPS), Complete Mini Protease
inhibitor cocktail tablet (Roche)). Cell lysate was sonicated
with ultrasound (5 s at amplitude 60 for three times)
and incubated for 1 h at 4◦C while rotating. Supernatant
was recovered after centrifugation at 14 000 rpm in a
FA-45–30–11 rotor (20 800 g) for 15 min at 4◦C. Protein
concentration was assessed using BCA Protein Assay kit
(Pierce) according to manufacturer’s instructions. Protein
separation was performed on 18% Criterion TGX Gel
(Bio-Rad) in 1× XT Tricine running buffer. A total of 30
g of protein lysate were heat denatured in 2× Laemmli
sample buffer (95◦C for 5 min) prior loading. Proteins
were transferred with Trans-Blot turbo transfer system
(Bio-Rad) on a nitrocellulose membrane (0.2mTrans blot
turbo, Bio-Rad). The following primary antibodies were
used: rabbit anti-RPL7 antibody (Bethyl, 1:2000), rabbit
anti-RPS15 middle region (Aviva System Biology, 1:1000),
rabbit anti-RPL34 (Abcam, 1:1000), anti-beta Actin (Ab-
cam, 1:5000). RPL7, RPS15 and RPL34 were detected
using goat anti-rabbit secondary antibody (IRDye800CW,
Licor,1:5000), b-Actin was detected using goat anti-mouse
secondary antibody (IRDye680CW, Licor, 1:5000). Signals
were visualized with the Odyssey Infrared Imaging Sistem
(LI-Cor Biosciences).
Data analysis
Mapping of ribosome footprints, DeepCAGE and RNAseq
reads. Ribosome footprints reads were aligned to both
transcriptome and genome references using a combined ap-
proach. Reads were first aligned to a transcriptome refer-
ence using Bowtie (41,42), with the following parameters:
-k 1 -m 20 -n 1, –best –strata –norc. An index transcriptome
reference was built based on RefSeq RNA sequences (ftp://
ftp.ncbi.nlm.nih.gov/refseq/M musculus/mRNA Prot/ last
modified 2013/05/08). Unmapped reads were then mapped
to theGRCm38/mm10 genome reference using Bowtie with
the following parameters: -k 1 -m 2 -n 1 –best –strata. For
each SAM file, reads shorter than 25 nt were filtered out.
SAM files were converted into a wiggle format, in which
only the 5′ end of each read was reported. For SAM files
obtained from the transcriptome alignment, transcriptomic
coordinates were converted into genomic coordinates and
stored into a wiggle format. Wiggle files are available at
http://gwips.ucc.ie/.
To retrieve corresponding genomic coordinates, we first
mappedRefSeq RNA sequences (the same used to build the
transcriptome reference) to the GRCm38/mm10 genome
assembly using GMAP (43), with the following param-
eters: -f samse -n0. The corresponding genomic coordi-
nates were used to convert the transcriptomic coordinates of
the mapped footprint reads. RefSeq RNA sequences which
mapped to the genome with insertions and/or deletions (in-
trons excluded) were not included when building the tran-
scriptome reference.Wiggle files of each alignment contain-
ing the 5′ ends of reads mapped were then merged.
DeepCAGE reads were trimmed to 27 nt and the first
nucleotide at the 5′ end was removed. Trimmed reads were
aligned to the GRCm38/mm10 genome reference, with the
following parameters: -m 10 -k 10 -n 2 –best –strata. For
CAGE tags mapping to multiple genomic locations, we ap-
plied a weighting strategy, based on the number of CAGE
tags within a 200 bp window around each candidate map-
ping location. A weight of 1.0 was assigned for uniquely
mapped sequences, for multi-mapped tags weight varied
from 0.0 to 1.0. Only tags with a weight equal or higher than
0.9 were kept (44).
Paired end RNAseq reads were aligned to RefSeq RNA
sequences (ftp://ftp.ncbi.nlm.nih.gov/refseq/M musculus/
mRNA Prot/) using Bowtie2 (45), with the following
parameters: -N 1 –norc.
Triplet periodicity analysis in ribosome footprints. Using a
custom PHP script the merged wiggle files were converted
to a format suitable for the Batch PositionConverter In-
terface in Mutalyzer (46) 2.0.beta-32 (https://mutalyzer.nl/
batch-jobs?job type=position-converter). These converted
files with genomic coordinates were manually loaded into
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Mutalyzer to retrieve positions relative to the annotated
TIS. The triplet periodicity pattern was analyzed by calcu-
lating the number of reads mapping in the first, second and
third nucleotide of each codon for all detected transcripts.
Positions were filtered out if they had coverage lower than
3 reads, or if they only mapped in intronic or intergenic
regions (500 nt upstream or downstream from annotated
coding regions) or if they only mapped to non-coding tran-
scripts. Since for samples treated with harringtonin the 5′
end of a footprint was expected to be located −12 nt far
from the TIS, positions located up to −15 nt were counted
as positions in coding regions. To calculate the triplet pe-
riodicity, positions shared by overlapping transcripts were
filtered as follows: if a position was shared between a cod-
ing and an untranslated region (3′ or 5′-UTR), the position
was counted only for the coding region; if it was shared be-
tween 3′-UTR and 5′-UTR of two overlapping transcripts,
the position closest to the coding region was reported, but
only if the difference in the distance of the two positions rel-
ative to the coding region was larger than 100 nt, otherwise
both positions were discarded.
Transcription start site assignment and annotation. TSSs
were assigned by summing the weighted number of CAGE
tags at each genomic position. Weighted numbers were
based on the MuMRescue software (44). Peaks located
within a window of 20 bp were merged and reported when-
ever the coverage was at least 10 tags per million (tpm) in at
least one experimental condition. BAMfiles were converted
into BED files and annotated based on RefSeq collection,
using intersectBed (BEDTools (47)). The RefSeq collection
was modified by extending the 5′-UTR of each transcript
with 500 nt. Peaks located more than 850 nt downstream
the annotated TSS were not considered for further analysis.
BAM files were converted into a wiggle format using cus-
tom scripts.
Translation initiation site assignment and annotation. A
dynamic local peak calling algorithm was developed to
identify TISs in the ribosome footprint data from harring-
tonin treated cells. To discriminate between genuine initia-
tion sites and noise, we evaluated the signal in the region
surrounding each peak. Peaks were first filtered following
the same procedures used for the triplet periodicity analy-
sis, except for positions shared by overlapping transcripts,
which were filtered as follows: if a position was shared be-
tween the 3′-UTR and a coding or 5′-UTR, the position
was counted only for the coding region or the 5′-UTR. Peak
calling was then performed after combining footprints from
three independent biological replicates. Each position with
a coverage of at least 20 reads was analysed and called if the
following conditions were met: the peak had higher cover-
age compared to any peak located 3, 6, 9, 12 or 15 bases
upstream; the peak showed a triplet periodicity pattern (the
two nucleotides following the peak had a summed cover-
age 40% or lower than the total coverage of that codon);
the five codons downstream should not contain a base with
a coverage higher than that of the peak analysed; the five
downstream codons, when having a coverage of at least 10%
of the peak analysed, should show a triplet periodicity pat-
tern. Once a peak was called, the analysis continued at the
next nucleotide, allowing the detection of TISs in different
frames. For each gene, the TIS with the highest coverage
was kept as reference, and any other TISs which had a cov-
erage lower than 10% of the reference TIS was discarded
for further analysis. For each called TIS, the coverage of
that peak in each individual sample was reported. TISs were
then classified into six categories: annotated TIS, 5′-UTR
(or unannotated 5′-UTR)TIS, coding TIS, 3′-UTRTIS and
multiple TIS. TISs mapping in position −12, −11 and −10
nt relative to the start codon were reported as annotated
TISs. TISs mapping upstream of position −12 were anno-
tated as 5′-UTR TISs (or unannotated 5′-UTR TISs if the
TIS was not located in the 5′-UTR sequence present in the
transcript’s reference sequence), TISs located between posi-
tion−10 and the stop codonwere annotated as codingTISs,
TISs located after the stop codonwere annotated as 3′-UTR
TISs, TISs which fell in more than one category were anno-
tated asmultiple (unless one of the categories was annotated
TIS, which was then the only one reported). Peaks located
5 kb downstream of the annotated start codon (counted
as transcript positions, not genome) were not considered
for downstream analysis. The background noise in these re-
gions was higher, likely because the ribosomes were not al-
lowed sufficient time to finish the translation of transcripts
on which they had already engaged in the elongation phase
at the start of the harringtonin treatment.Wiggle files show-
ing all the mapped footprints are available and visualized at
http://gwips.ucc.ie/.
Differential expression analysis and functional annotation.
For RNAseq, CAGE and ribosome profiling data, custom
scripts were used to quantify the number of mapped reads.
For miRNAseq data, the E-miR software package was used
to map trimmed sequencing reads and quantify the num-
ber of mapped reads (40). The statistical programming lan-
guage R (version 2.15.1) was used for analysis of differ-
ential expression between myoblasts and myotubes. The
analysis was performed using the R Bioconductor package
edgeR (48) (version 3.0.8). A negative binomial model was
fitted and GLM Tag-wise dispersion was estimated prior
testing procedures. Exact P-values were computed using
the exact test and adjusted for multiple testing according
to Benjamini–Hochberg method (49). Differential expres-
sion analysis was performed at gene level after summing
reads mapped to Refseq sequences (ftp://ftp.ncbi.nlm.nih.
gov/refseq/M musculus/mRNA Prot/). KEGG (Kyoto En-
cyclopedia of Genes and Genomes) pathway analysis was
performed using DAVID Functional Annotation Tool (50).
Statistical model to identify genes with alternative TIS
or TSS usage. We fitted the previously published lo-
gistic generalized linear mixed model (51) to the counts
for each TIS (or TSS) using fixed effects for location,
myotube, and their interaction, and a random intercept
and location effect within cell culture. The model was
fitted using R Bioconductor package lme4.0 (R version
2.15.1, http://cran.r-project.org/web/packages/lme4/index.
html. Chi-squared likelihood ratio tests were used for
testing the presence of location-myotube interactions, i.e.
switches in TIS (or TSS) usage. Both a global chi-squared
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likelihood ratio test for the presence of any interaction and
t-tests for individual effects per TIS were calculated.
Codon usage, uORFs and out-of-frame analysis. For each
TIS, the nucleotide sequence of the codon was reported
based on RefSeq. For 5′-UTR TISs, sequences were re-
ported up to the annotated TIS and translated into the cor-
responding amino acid sequence until the first stop codon
or the annotated TIS. For TISs in unannotated 5′-UTR, the
genomic sequences were retrieved from GRCm38/mm10
genome assembly using the genomic Refseq reference se-
quences). For any TIS located in the 5′-UTR and leading
to a stop codon (upstream or downstream of the annotated
start codon), the length of the amino acid sequence was cal-
culated. The frame of coding TISs was defined by dividing
the mRNA position (adjusted for the distance of the 5′ end
of the read relative to the actual TIS position) by 3.
IRES and 5′ TOPanalysis. The 5′-UTR sequences of tran-
scripts containing TISs in their 5′-UTRand transcripts con-
taining TISs only in the annotated TIS and/or the cod-
ing region were retrieved from Refseq using UCSC Ta-
ble Browser. Fasta files were uploaded into UTRScan (52)
(http://itbtools.ba.itb.cnr.it/utrscan/help) and analysed for
IRES and 5′ TOP motifs. Enrichment was calculated by
comparing the number of transcripts containing IRES and
TIS in the 5′-UTR versus those containing IRES but no
TISs in the 5′-UTR. Transcripts containing IRES were then
overlapped with transcripts containing uORFs.
In silico screening of alternative TISs. Raw MS/MS
proteomic datasets were retrieved from PRoteomics
IDEntifications (PRIDE) database (accession numbers:
PXD000328, PXD000022, PXD000065). Amino acid
sequences for 24665 Mus Musculus proteins were retrieved
from UniProt (http://www.uniprot.org/uniprot/?query=
organism%3A%22mus+musculus%22+AND+reviewed%
3Ayes+AND+keyword%3A1185&sort=score) in fasta
format and used as background reference. A fasta file
containing amino acid sequences of a set of candidate
alternative and uORFs was created and merged with the
UniProt reference file. For candidate ORFs containing
non-canonical start codons, an alternative peptide sequence
was included, where the first amino-acid was replaced with
methionine. The MS/MS analysis was performed using the
Trans-Proteomic Pipeline v 4.6.3 (53). The raw MS/MS
data were converted to mzXML and peptides identified
by X!Tandem. The output files were then processed with
PeptideProphet for spectrum-level validation and only
spectra with probability greater than 0.90 were reported for
manual inspection.
Accession codes and hyperlinks to public repositories.
Raw deep sequencing data from the C2C12 RNAseq,
miRNAseq and ribosome footprint profiling are available
for download at EuropeanNucleotide Archive (http://www.
ebi.ac.uk/ena) under accession number PRJEB7207. Wig-
gle files of ribosome profiling data from cycloheximide
and harringtonin experiments are available at http://gwips.
ucc.ie/ and can be visualized as ‘Elongating Ribosomes’
and ‘Initiating Ribosomes’ tracks, respectively. All analy-
sis scripts together with a README file containing in-
structions for users are publicly available at GitHub: http:
//lumc.github.io/ribosome-profiling-analysis-framework/.
RESULTS
A simplified ribosome profiling protocol
The standard protocol for ribosome profiling (25) involves
numerous steps, including the isolation of the protected
ribosome footprints from the monosomes, obtained by
RNAse digestion of cytosolic extracts and the conversion
of the small single stranded RNA footprints into a double
stranded DNA sequencing library. The conversion is usu-
ally accomplished by ligation of single stranded adapters
to the 3′ ends of the RNA footprints, followed by reverse
transcription and circularization. The circular template is
then used for polymerase chain reaction amplification (Fig-
ure 1A). Each of these stepsmay be subject to certain biases.
We simplified the existing method by converting the ribo-
some footprints into sequencing libraries with a standard
small RNA sample preparation protocol, which avoids the
multistep circularization procedure. Double stranded RNA
adapters were ligated to the small RNA footprints, reverse
transcribed and directly amplified for sequencing. This re-
sulted in high quality ribosome footprints, as evidenced
from the analyses described below. The complete protocol
is available in the extended experimental procedures.
Analysis pipeline
High quality ribosome footprints are characterized by a dis-
tinct triplet periodicity pattern originating from the translo-
cation of a ribosome from one codon to the next during
translation elongation. In case of initiating ribosomes, the
first nucleotide of each read is usually 12 nt upstream of
the start of the codon that is being translated (25,54). These
characteristics are commonly used as metrics for the qual-
ity of ribosome profiling data.We developed a custom script
to analyze the triplet periodicity pattern by converting the
first position of the aligned reads to transcript coordinates
and relating those coordinates to annotated TISs and the
reading frame downstream of the annotated TIS. The script
reports the number of reads mapping to the first, second
and third nucleotide of each codon for all detected coding
transcripts and the number of reads in each position relative
to the annotated TIS. The results of this procedure clearly
show in our data that ∼80% of reads mapped to the first
nucleotide of each codon, as expected from previous stud-
ies (28,54,55) (Figure 1B top, 1C, Supplementary Table S1).
For all samples, a major peak was observed at −12 nt from
the annotated TIS, which is in accordance with previously
reported data on the size and the position of the fragment
protected by the ribosome (25,54). A higher percentage of
5′ end reads mapping −12 nt from the annotated TIS was
also observed for footprints generated by halting initiation
of translation (harringtonin treated cells) compared to foot-
prints generated by halting translation elongation (cyclo-
heximide treated cells), as expected (Figure 1D).
The alignment of short (28–29 nt (Supplementary Fig-
ure S1)) ribosome footprints represents a challenge because
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Figure 1. Generation and quality control of the ribosome profiling datasets. (A) An outline of our experimental procedures. The initial steps include the
halting of ribosomes on the mRNA by harringtonin or cycloheximide, the treatment of cytosolic extracts with RNAse and the isolation of monosomes
on sucrose gradients. These steps are identical to the original protocol developed by Ingolia etal. (23). The original protocol further includes the steps
indicated in the left panel: single stranded adapters are ligated to the 3′ ends of the RNA footprints (1), reverse transcribed (2,3) and circularized (4)
prior to amplification (5). The right panel shows our simplified sample preparation protocol. Double stranded RNA adaptors, with an overhang of six
degenerated nucleotides, are ligated to the RNA footprints (1). Footprints are reverse transcribed (2,3) and amplified for sequencing (4). (B) Percentage
of reads mapped to the first, second and third position of each codon in all detected translated transcripts (top) and number of reads (bottom) mapped to
the genome reference (light bars) or to combined transcriptome and genome reference (dark bars). (C) A screenshot of UCSCGenome browser displaying
the triplet periodicity of the 5′ ends of footprints mapped to Acta1 gene. Harringtonin and cycloheximide treated myoblasts are shown as independent
traces. The y-axis represents the coverage of the highest peak. On top of the coverage tracks, the first, second and third nucleotide positions are shown for
each codon for the first 27 nt of the first exon. Arrows display the distance of the highest peak relative to the annotated start codon. (D) Number of reads
mapped to the first 2 codons and up to 21 nt upstream the start codon for harringtonin (dark yellow) and cycloheximide (light yellow) treated myoblasts.
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footprints often span splice junctions, with short overhangs
on either side of the junction. We calculated that 5421
murine transcripts (Supplementary Table S2) contain a TIS
that is not mappable by standard genome alignment, be-
cause the TIS is located within a splice junction or it is lo-
cated <15 nt upstream or downstream an exon–exon junc-
tion. Common procedures to avoid loss of reads crossing
exon–exon junctions use splicing-aware short-read align-
ment programs such as TopHat v1 (25,56). Alternatively,
reads were mapped to the genome reference using a stan-
dard short read aligner, followed by the mapping of un-
aligned reads to known splice junctions using TopHat v1
(57). Both analyses are potentially flawed by the subopti-
mal performance of TopHat v1 on reads that are as short as
30 nt. Even though the upgraded TopHat2 performs better
in the alignment of exon–exon junction reads that extend
10 nt or less into one of the exons (58), its performance has
been optimized for long paired-end reads. Another prob-
lem in the genomic mapping of short RNA-derived reads
is the presence of pseudogenes. The alternative of mapping
exclusively to the transcriptome is also not ideal because it
may miss hits in unannotated transcripts or in unannotated
parts of transcripts, such as alternative first exons (59).
To overcome these limitations, we performed a combi-
nation of transcriptome and genome alignment. Footprint
reads were aligned to a transcriptome reference, and only
reads that did not map to the transcriptome were aligned to
the genome (Supplementary Table S3). Mapping first to the
transcriptome and then to the genome slightly reduced the
number of reads mapping to pseudogenes (Supplementary
Tables S4 and S5). The coordinates from the reads mapping
to the transcriptomewere converted to genomic coordinates
and then combined with the mappings from the genome
alignment. The improvements obtained by the combined
alignment can be appreciated by the recovery of ∼30% of
otherwise unmappable reads. These reads are likely genuine
ribosome footprints as they show a triplet periodicity iden-
tical to the reads that do not span exon–exon junctions (Fig-
ure 1B, bottom).
A dynamic local peak calling algorithm was then devel-
oped to identify TISs in the ribosome footprint data from
harringtonin treated cells. The developed algorithm evalu-
ates the signal in the region surrounding each peak, takes
into account the triplet periodicity in the nearby codons and
is able to report start codons in different frames. A complete
description is available in ‘Materials and Methods’ section.
Scripts used for the combined alignment, triplet periodic-
ity analysis and peak calling are publicly available at http:
//lumc.github.io/ribosome-profiling-analysis-framework/.
Experimental setup
We performed ribosome profiling on undifferentiated my-
oblasts and differentiatedmyotubes from themurineC2C12
cell line, a well-characterized model for skeletal muscle dif-
ferentiation (60). Ribosome footprints were recovered from
initiating ribosomes and elongating ribosomes after halt-
ing translation with harringtonin or cycloheximide, respec-
tively, analyzing three independent cultures for each condi-
tion.
Ribosome footprints derived from coding and non-coding
genes
Footprints recovered after halting translation with harring-
tonin or cycloheximide mainly mapped to protein coding
genes (Figure 2A, Supplementary Tables S4 and S5). Reads
mapping to repetitive sequences, including contamination
from ribosomal and transfer RNAs, are shown separately
in Supplementary Table S3.
In addition, a relative high proportion of readsmapped to
long intergenic non-coding RNAs (lincRNAs) (between 5
and 10% in average) and small RNAs (between 10 and 20%
in average). To address the coding potential of lincRNAs
in our dataset, we compared the read length distribution of
footprints mapping to coding genes, non-coding genes (all
genes with accession prefix ‘NR ’ in the RefSeq collection,
including also lincRNAs) or only lincRNAs (Figure 2B).
Footprints mapping to protein-coding genes were preferen-
tially 29 nt long, whereas footprints from non-coding genes
did not show this preference in length. The read-length dis-
tribution of footprints mapping only to lincRNAs was sim-
ilar to the one of footprints mapping to any other non-
coding genes. Nevertheless, in both cases a portion of reads
was 27–30 nt long.
We identified highly covered lincRNAs with protected
fragments of 27–36 nt (e.g.Malat1) or with a preference for
reads 27–30 nt long (e.g. Snhg1, Rnu11, H19) (Figure 2C).
Malat1 reads mapped along the full body of the transcript,
it did not show a preferential peak at AUG codons nor
other common non-AUG start codons and it lacked of a
drop of coverage at any corresponding stop codon (Fig-
ure 2D). Snhg1 showed coverage in intronic regions tran-
scribing for snoRNAs, as previously reported in the Gas5
transcript (Figure 2E) (61). The coverage in Rnu11 (Figure
2F) and H19 (Figure 2G) was restricted to one or two re-
gions, and no difference was shown between the cyclohex-
imide and harringtonin treatment. Based on these obser-
vations, we suggest that the majority of footprints deriving
from lincRNAs in our dataset do not have a coding poten-
tial.
Subsets of mRNAs primarily regulated at translational level
during myoblasts differentiation
To investigate the impact of translational regulation inmyo-
genesis, ribosome profiling data were compared to regu-
lar RNAseq data on total poly(A)+ RNA. The numbers
of genes detected by ribosome profiling and RNAseq were
similar (Supplementary Figure S2). Switches in the abun-
dance of known markers of myogenesis were observed in
both the RNAseq and the ribosome profiling data, as exem-
plified by the upregulation of the myogenic markersMyog,
Tnnc1 and Myh7, and the downregulation of Myf5 (Sup-
plementary Table S6).
Differential expression between myoblasts and myotubes
was analysed at the gene level and the calculated log fold
changes were compared between ribosome-bound RNAs
(Supplementary Tables S7 and S8) and total RNA (Supple-
mentary Table S9). Overall we observed a positive corre-
lation between total and ribosome-bound RNAs (r = 0.71
and 0.65 for cycloheximide and harringtonin footprints, re-
spectively, Pearson correlation) (Figure 3). However, the
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Figure 2. (A) Percentage of reads mapped to coding and non-coding genes in myoblasts and myotubes treated with harringtoning (Har) or cycloheximide
(Chx). (B) Read-length distribution of footprints mapping to protein-coding genes (top), non-coding genes (including small and long non-coding genes) or
only to lincRNAs (bottom). (C) Read-length distribution of footprints mapping toMalat1, Snhg1, Rnu11 andH19. (D–G) Coverage patterns forMalat1,
Snhg1, Rnu11 and H19 in harringtonin (top traces) and cycloheximide (bottom traces) treated myoblasts.
 at K
atholieke U
niversiteit on M
arch 21, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2015 9
Figure 3. Changes in transcription and translation during myogenesis. Scatterplot showing differences in total RNA (x-axis) and ribosome-associated
RNA (y-axis) from harringtonin (A) or cycloheximide (B) treated myoblasts and myotubes. Each data point represents the log-transformed fold change
between myotubes and myoblasts. The red line indicates the slope, whereas the black line indicates the diagonal.
fold change observed in ribosome-bound RNA is gener-
ally lower than the fold change in total RNA, as demon-
strated by the slope of the regression line (0.46 for cyclo-
heximide footprints [95% confidence interval: 0.457–0.474]
and 0.42 for harringtonin footprints [95% confidence inter-
val: 0.413–0.431]). This is indicative for a general damp-
ening effect of translational regulation. A subset of genes
showed discrepant total and ribosome-bound RNA lev-
els. In harringtonin-treated C2C12 (Figure 3A), 5680 genes
showed significant changes between myoblasts and my-
otubes (P-value < 0.05) in total RNA but not in ribo-
some boundRNA levels, indicative of a dampening effect of
translation on transcription-induced changes. A total of 431
genes were regulated exclusively at translational level but
not at the transcriptional level. Finally, 544 genes were regu-
lated in opposite direction, meaning that they were upregu-
lated at transcriptional level but showed lower translational
efficiencies or vice versa. In cycloheximide-treated cells (Fig-
ure 3B), a similar trend was observed, even though the num-
ber of genes that reached a statistical significance (P-value
< 0.05) was lower (6902 genes were regulated during tran-
scription but dampened at translational level, 66 genes were
regulated only at translational level and 73 showed anti-
directional changes).
We next addressed the contribution of miRNAs on the
regulation of gene expression at the level of translation. We
found 105 miRNAs differentially expressed between my-
oblasts and myotubes (Supplementary Table S10) in our
miRNAseq data, of which 66 were upregulated. We then
focused on the effect of nine well-characterized myomiRs
(mir-206, mir-1a, mir-22, mir-27b, mir-133a, mir-155, mir-
29c, mir-675 andmir-181a-5p) and compared the calculated
log fold changes of experimentally validated targets between
ribosome-bound RNAs (cycloheximide treatment) and to-
tal RNA. For 8 out of 9 analyzedmyomiRrs, the correlation
in fold change of their targets was not significantly differ-
ent from the general correlation (Supplementary Table S11,
Figure S3). These data suggest that miRNA regulation does
not contribute strongly to the observed translational regu-
lation (Figure 3).
We continued our comparison of transcriptome and
translatome by performing a pathway enrichment analysis
(Supplementary Table S12) on the subsets of genes show-
ing discordant regulation. mRNAs coding for ribosomal
proteins displayed the highest enrichment in the subset of
genes showing opposite regulation between transcription
and translation (these genes were downregulated at trans-
lational level but upregulated at transcriptional level, P-
value 2.2 × 10−7), and in the subset of genes downregu-
lated only at translational level (P-value 3.7 × 10−13). mR-
NAs involved in the proteasome pathway showed a moder-
ate enrichment in the subset of oppositely regulated genes
(P-value 3.5 × 10−5), followed by mRNAs involved in fo-
cal adhesion (P-value 3.3 × 10−4), regulation of actin cy-
toskeleton (P-value 7.7 × 10−4) and calcium signaling (P-
value 2 × 10−2). To determine whether the discordant reg-
ulation was affecting the full pathway or only a subset, we
compared log fold changes of all genes belonging to each
enriched pathway.
The correlation observed between RNAseq data and ri-
bosome profiling data for all genes that are part of the cal-
cium signaling pathway was high (r = 0.84 for both cy-
cloheximide and harringtonin footprints, Pearson correla-
tion), suggesting that only a subset of calcium signaling
genes is differentially translated. Similar high correlations
were observed for all the other pathways, except for riboso-
mal protein genes. A poor correlation was found between
RNAseq data and ribosome profiling data for ribosomal
genes, when comparing RNAseq and harringtonin foot-
prints (r = 0.27, Pearson correlation, P-value = 0.0018)
(Figure 4A). The comparison between RNAseq and cyclo-
heximide footprints, however, showed a positive correlation
(r = 0.79, Pearson correlation, P-value < 2.2e-16) (Fig-
ure 4B). The discrepancy between ribosome footprints of
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Figure 4. Translational regulation of ribosomal protein genes. Scatterplots show differences in levels of transcribed and translated ribosomal protein genes.
Total RNA (x-axis) and ribosome-associated RNA (y-axis) from harringtonin (A) or cycloheximide (B) treated myoblasts and myotubes are shown for
145 genes belonging to the ribosome KEGG pathway. (C) A screenshot of UCSC Genome browser displaying alternative translation start sites (TISs, first
and second traces) and transcription start sites (TSSs, third and fourth traces) in myoblasts and myotubes of the ribosomal protein gene Rpl7. TSSs and
TISs leading to the translation of the pORF (TIS1) or predicted alternative open reading frame (TIS2) are indicated by red arrows.
initiating and elongating ribosomes suggested that not all
initiating ribosomes were leading to translation of the ORF
and/or that ribosome stalling was affecting the counts for
elongating ribosomes. We therefore focused on the charac-
terization of translation initiation.
Characterization of translation initiation in myogenesis
Data from harringtonin-treated cells were used to identify
TISs used in myoblasts and myotubes.
After mapping and filtering procedures, and combining
the reads from the triplicate experiments, 3,052,146 and
976,468 reads were used to assign TISs in myoblasts and
myotubes, respectively. The above described dynamic local
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peak calling algorithm was used to discriminate between
noise and genuine initiation sites in the surrounding re-
gion of each peak. We detected a total of 6823 TISs in my-
oblasts (Supplementary Table S13) and 2371 TISs in my-
otubes (Supplementary Table S14), corresponding to 4106
and 1561 coding genes, respectively. Our analysis showed
that ∼45% of the detected genes in myoblasts had two or
more TISs, whereas in myotubes the percentage was slightly
lower (∼30%) (Figures 5A and 5B). The number of genes
with more than six TISs was only ∼0.5 and 0.6% in my-
oblasts and myotubes, respectively.
Approximately 50% of the footprints coincided with an-
notated start codons (Figure 5C), whereas ∼20% mapped
in the 5′-UTRs (of which 6.5% in unannotated 5′-UTRs,
<500 nt upstream of the annotated start codon). A consid-
erable amount of footprints (∼30%) were found within cod-
ing regions, ∼5% of which led to in-frame ORFs, hinting
at alternative start codons for protein isoforms with trun-
cated N-termini for 107 genes in myoblasts and 50 genes
in myotubes. No general shift in the localization of TISs
was observed during myogenic differentiation (Figure 5C).
Around 55% of the footprints in the detected TISs con-
tained the canonical AUG codon (Figure 5D). Notably,
footprints of TISs located in the 5′-UTRs were enriched
for alternative codons, primarily CUG and GUG, in accor-
dance with the notion that uORFs frequently use weaker,
non-canonical start codons (Figure 5E) (24,26,28,60). Foot-
prints of TISs located in the unannotated 5′-UTRs were
also mainly mapping to the non-canonical codons CUG
and GUG (Supplementary Tables S15 and S16), except in
myoblasts where the percentage of footprints with a canon-
ical AUG codon was higher (32 against 16% in myotubes).
This discrepancy mainly originated from footprints map-
ping to two TISs, corresponding to the highly expressed
splicing factor Sf3b6 and mitochondrial gene Prelid1 (Sup-
plementary Figure S4). These two detected TISs were fol-
lowed by a stop codon upstreamof the pORFs, according to
the genomic sequence, but no TISs were detected at the an-
notated start codons, which may be due to the sort distance
between uORF and annotated TIS. Since the unannotated
5′-UTR sequence may contain intronic sequences, it is im-
possible to determine whether these TISs represent uORFs
or genuine start codons from wrongly annotated genes.
To distinguish between uORFs and alternative extended
N-termini, we focused on TISs located in the annotated 5′-
UTRs, and we classified them based on their reading frame
in relation to the pORF and the presence of stop codons.
Sixty percent of the detected TISs located in the 5′-UTRs
were leading to stop codons prior the start of the pORFs
(corresponding to 1274 TISs and 380 TISs in myoblasts
andmyotubes, respectively) (Figure 6A). The length of these
uORFs ranged from 1 tomore 100 amino acids (Figure 6C),
but the majority (∼85%) were between 1–30 amino acids
(50% was shorter than 10 amino acids). The remaining 40%
of the TISs located in 5′-UTRs were not leading to stop
codons prior the start of the pORF, but ∼72% of these
uORFs was in a different reading frame than the pORFs,
leading to overlapping uORFs, whereas the remaining 28%
was in-frame with the pORF, suggesting the presence of iso-
forms with extended N-termini (Figure 6B). The length of
the overlapping uORFs was longer than the one of the non-
overlapping uORFs, reaching up to 400 amino acids and
with only ∼40% being shorter than 30 amino acids (Fig-
ure 6D). We then investigated whether the usage of TISs
in the 5′-UTRs sequences was associated with the presence
of known regulatory elements, such as Internal Ribosome
Entry Sites (IRESs) and Terminal Oligopyrimidine Tracts
(5′ TOP). A significant enrichment of predicted IRES was
found in transcripts with TISs in the 5′-UTRs, compared to
transcripts for whichwe detected TISs only in the annotated
start codon and in the coding region. 36% of the transcripts
containing TISs in the 5′-UTR had IRESs (Supplemen-
tary Table S17), whereas the percentage dropped to 24 for
transcript without TISs in their 5′-UTRs in myoblasts (27
against 20% in myotubes, respectively). No significant en-
richment was found for predicted 5′ TOPs (Supplementary
Table S18), and overall the percentage of transcripts with a
TIS in the 5′-UTR and the presence of a predicted 5′ TOP
was lower compared to the percentage of transcripts con-
taining predicted IRES (∼4% for both myoblasts and my-
otubes). These results suggest that for these genes uORFs
do not play an important role in the regulation of mRNAs
starting with a 5′ TOP in myogenesis, whereas they may fa-
vor the use of IRESs in a subset of genes.
Alternative translation initiation independent of alternative
promoter usage
Differences in TIS usage during skeletal muscle differen-
tiation could derive from regulation at the transcriptional
level, due to alternative promoter usage. Alternatively, a
switch in TIS usage may occur in the same transcript and
arise from regulation at the translational level, because of
differential recognition of upstream or alternative ORFs
due to altered activity of translation initiation factors or
RNA binding proteins. Regulation at the translational level
can also occur through different efficiency in the transla-
tion of transcript variants. An example of a gene with a
combination of both scenarios is Tpm3, a cytoskeletal pro-
tein involved in the calcium dependent regulation of muscle
contraction. Two different TISs were detected in Tpm3: one
TIS arising from a shorter transcript was predominantly
used in myoblasts, another TIS arising from a longer tran-
script with alternative first exons was predominantly used
in myotubes (Figure 7A). This results in the formation of
proteins with two distinct N-termini, a longer isoform of
285 aa (UniProt P21107–1, also known as skeletal muscle
isoform) and a shorter isoform of 248 aa (P21107-2, also
known as cytoskeletal isoform). In addition to the nature of
the transcribed protein, the efficiency of translation seems
to be tightly controlled. As a measure for translational ef-
ficiency and to assess the effects of changes in TSSs, we
analysed DeepCAGE data to detect 5′-ends of transcripts.
DeepCAGEdata for the same gene in the same cells showed
three different TSSs. The most distal (3′) TSS does not ap-
pear to code for a protein. The other two code for the short
(cytoplasmic) and long (skeletal muscle) transcript variants
and were transcribed at similar levels in myotubes (Fig-
ure 7B). However, the short variant was not translated in
myotubes, but only in myoblasts (Figure 7A). Interestingly,
tropomyosin proteins have already been shown to be reg-
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Figure 5. Alternative translation initiation sites used during myogenesis. Bar graph shows (A) the number of TISs per gene in myoblasts (green bars) and
myotubes (purple bars), (B) the percentage of genes containing one, two or more than two TISs, (C) the percentage of TISs located in the 5′-UTRs, in
the annotated start codons, in the coding regions or in the 3′-UTRs. Multiple indicates TISs mapping to more than one of the listed categories. (D) Pie
chart shows the percentage of reads containing AUG and non-AUG codons at all detected TISs for myobalsts (left) and myotubes (right) treated with
harringtonin. (E) Distribution of reads with AUG and non-AUG codons at detected TISs located in the 5′-UTRs, in the annotated start codons and in
the coding regions. Distribution is shown only for myoblasts.
ulated at translational level in slow-twitch and fast-twitch
muscles (62).
To investigate the extent of translational regulation dur-
ing myogenesis, we assessed the statistical significance of
TIS switches for all genes with more than one TIS. From
4219 genes for which we could identify TISs, 1729 genes
contained at least two TISs. Out of those, 312 genes (18%)
(Supplementary Table S19) showed a significant difference
(P-value < 0.05, after multiple testing correction) in alter-
native TIS usage between myoblasts and myotubes. To ac-
count for changes derived from regulation at transcriptional
level, we performed the same analysis to detect changes
in TSS usage as detected by DeepCAGE. Out of 6426 de-
tected genes, 635 genes contained two or more TSSs, and
28% (180) of those showed a significant change (P-value
< 0.05, after multiple testing correction) in TSS usage be-
tween myoblasts andmyotubes (Supplementary Table S20).
The overlap between genes with both changes in TISs and
TSSs usage was small (Figure 8A), indicating that the ma-
jority of switches in TIS are occurring in transcripts with the
same start site. Even transcripts with a switch in both TIS
and TSS usage appeared to be at least partly regulated at
the translational level. Cryab is an example of such a tran-
script. Twomajor TSSs were detected in myoblasts, whereas
in myotubes only one of the two TSS was detected (Fig-
ure 8B). Ribosome footprints from myoblasts showed (i)
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Figure 6. Potential uORFs used during myogenesis. (A) Percentage of TIS located in the 5′-UTRs leading to a stop codon before the annotated start codon
of the pORF (non-overlapping uORFs) or overlapping the pORF. (B) Percentage of TISs in-frame and out-of-frame with the overlapped primary ORF.
(C) Length distribution of non-overlapping and (D) overlapping uORFs in myoblasts (green) and myotubes (purple).
a TIS in the 5′-UTR, which represents an uORF with an
harringtonin peak corresponding to an AUG start codon
in a Kozak consensus sequence, and cycloheximide foot-
prints on the entire 35 amino acids uORF, in addition to
(ii) a TIS representing the pORF (Figure 8C). In myotubes,
however, only the TIS corresponding to the annotated start
codon was detected. Ribosome profiling footprints of cy-
cloheximide treated cells showed a significant upregulation
of Cryab in myotubes compared to myoblasts (Supplemen-
tary Table S8). This indicates a negative effect of the uORF
on translation in myoblasts. The short distance between the
uORF and the pORF, plus the relatively long uORF (35
amino acids) suggest that translation re-initiation in my-
oblasts is impaired. In agreement with our finding, a previ-
ous study has shown upregulation of Cryab at protein level
in myotubes (63).
To identify which other genes are likely subjected to
translational regulation by expression of uORFs, we se-
lected genes with a significant switch between the anno-
tated TIS and a TIS in the 5′-UTR region, as evident from
the interaction P-value of relative TIS usage and differen-
tiation status (Supplementary Table S21). This led to the
identification of 27 genes containing uORFs regulated dur-
ing differentiation. Many of these genes, including Cryab
(63,64), Vim (65), Spp1 (66), Eno3 (67,68), Pgam (69), Agl
(70), Tmbim6 (71), Asb8 (72) and Cs (73), are known to be
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Figure 7. Alternative transcription and translation in Tpm3. On top of the coverage tracks, the six annotated transcripts are shown. (A) Two translation
initiation sites (TISs, indicated by red arrows) arise from two transcript variants and are differentially used in myoblasts (first trace, harringtonin) and
myotubes (third trace, harringtonin). Footprints in the complete open reading frame are shown for myoblasts (second trace, cycloheximide) and myotubes
(fourth trace, cycloheximide). (B) Two TSSs (indicated by red arrows) are used in myoblasts (top trace) and three TSSs are used in myotubes (bottom trace).
involved in the development, regeneration and/or home-
ostasis of skeletal muscles in humans (Table 1). Moreover
Eno3 (74,75) and Spp1 (76) have been recently reported
as biomarkers for Duchenne muscular dystrophy, where
their protein expression levels changes inDuchenne patients
through molecular mechanisms not yet fully understood.
KEGG pathway analysis on the complete set of genes
with changes in alternative TIS usage showed moderate en-
richment of only two pathways, ribosomal proteins genes
and genes involved in the calcium signaling pathway (Sup-
plementary Table S22), pathways that were also enriched in
a comparison of transcriptome versus translatome (Supple-
mentary Table S12). None of the 27 genes with switches in-
volving uORFs was listed in the set of genes belonging to
these two pathways, indicating that the observed switches
identified in ribosomal protein genes and calcium signaling
genes were mainly occurring between an annotated TIS and
a TIS in the coding region, or between different TISs in the
coding region. Another plausible explanation is the imper-
fect annotation of KEGG pathway, as seen for Tmbim6, a
gene involved in calcium signaling (76) but not listed in the
calcium signaling pathway (mmu4020).
Switches between alternative TISs which were observed
in ribosomal genes were indeed mainly occurring between
the annotated TISs and alternative TISs located down-
stream in the coding region. These switches were not due
to alternative TSS usage as generally only one TSS was
found. An example of such a ribosomal protein gene is
Rpl7 (Figure 4C). The TIS detected in the coding region
may lead to translation of a shorter novel protein, con-
taining a methionine at its start codon and translated in
a different frame compared to the pORF. This aORF may
therefore represent a dual coding region. Rpl7 was down-
regulated at total RNA level, but the downregulation did
not reach significanctly in both ribosome profiling datasets.
We determined RPL7 protein level by western blot analy-
sis, and detected similar protein expression levels between
myoblasts and myotubes (Supplementary Figure S5), sug-
gesting that the alternative out-of-frame TIS does not af-
fect the translation of the pORF and that the downregula-
tion observed at total RNA level is buffered during trans-
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Figure 8. Switches in TISs usage during myogenesis. (A) Venn diagram showing the overlap between genes with significant switch in TSSs usage and genes
with significant switch in TISs usage. The total number of genes with significant switches in TSS or TIS usage is reported between parentheses. (B) Coverage
pattern and position of alternative TSSs used in Cryab gene, for myoblasts (top trace) and myotubes (bottom trace). TSSs are indicated with black arrows.
(C) A screenshot of UCSC Genome browser displaying translation start sites (harringtonin, first and third traces) and ribosome footprints for the whole
coding region (cycloheximide, second and fourth traces) in Cryab. TISs located in the annotated start codon (pORF) and in the 5′-UTR (uORF) are
indicated with black arrows. Below the coverage tracks, the nucleotide sequence of the genomic region between the uORF and the pORF is shown. The
stop codon in-frame with the uORF is indicated.
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Table 1. Candidate uORFs differentially used during myogenesis, in genes with biological and/or clinical relevance in muscle biology
Gene symbol Biological and/or clinical relevance TIS position (5'-end) Start codon Length (aa) uORF peptide sequence Type of uORF
Cryab AlphaB-crystallin modulates myogenesis by altering MyoD levels.
CRYAB levels increase during differentiation, leading to an increase of
MYOD levels. Loss of CryAB alters the capability of satellite cells to
regenerate skeletal muscle. 
chr9:50753019 AUG 35 MTSHRSAQPCLCFSFLSSVSTGYV
SPCQIPDHKSP
Not overlapping
chr9:50753228 UUG 47 LTSQPTLHSSSHNGHRHPPPLDPA
PLLPLPLPKPPLRPVLRRAPVGV
Overlapping
Spp1 Osteopontin is a target of MyoD and Myf5 and a biomarker for
Duchenne muscular dystrophy.
chr5:104435126 CAU 20 HPCLGLQSSAAGILGGNQPR Not overlapping
chr5:104435168 GGA 6 GGNQPR Not overlapping
Eno3 The beta-subunit of the glycolytic enzyme enolase is upregulated at
transcriptional level during differentiation of myoblasts. Mutations in
this gene have been associated to muscle beta-enolase deficiency,
which leads to glycogen storage disease. Eno3 is a biomarker for
Duchenne muscular Dystrophy.
chr11:70657801 UCU 64 SSSLRDQLSTLAHSHLLWCSHGH
AKNLRPGNPGLQGQPHGGGGPA
HSQGSIPSSCAQWSFHGYL
Overlapping
Pgam Phosphoglycerate mutase is regulated at transcriptional level during
myogenesis and dysfunction of Pgam leads to metabolic myopathy.
chr19:41911995 UCG 21 SAILSCCCILCPSPWLPTSWC Overlapping
Agl Glycogen debranching enzyme is involved in glycogen storage
disorders (Cori’s and Lafora’s disease).
chr3:116807384 GUU 19 VRILQKPKWNTVSRFEFYY Overlapping
Tmbim6 The BAX inhibitor motif containing 6 gene modulates calcium
homeostasis in the endoplasmatic reticulum.
chr15:99399869 CUG 10 LNRLWSHEYI Overlapping
chr15:99393038 UGU 4 CPVL Not overlapping
Asb8 Ankyrin repeat and SOCS box gene 8 is expressed predominantly in
skeletal muscle (i). A member of the same family (Asb15) regulates
skeletal muscle growth by stimulating protein synthesis and regulating
differentiation of muscle cells.
chr15:98145607 UUG 7 LEHVNTL Not overlapping
Cs Citrate synthase is a mitochondrial enzyme regulated during
myogenesis, when mitochondrial content rapidly increases.
chr10:128337852 CUG 1 L Not overlapping
Vim Vimentin is expressed during the starting phase of differentiation and
decreases during development progression in C2C12.
chr2:13574376 UUG 45 LQFFQPQQASPPSKPCLPGLCPRP
PTAGCSVAPAHRAGPAPTGAM
Overlapping
lation. Western blot was also performed for two other ribo-
somal proteins, RPL34 and RPS15, where the detected al-
ternative TISs in the coding regions were in-frame with the
pORFs. Rpl34 was shown to be significantly upregulated
at total RNA level, whereas it was downregulated in har-
ringtonin footprints (the downregulation did not reach sig-
nificance in cycloheximide footprints). Rps15 was not dif-
ferentially expressed at total RNA levels but, similarly to
Rpl34, harringtonin footprints showed a downregulation
in myotubes (which did not reach significance in cyclohex-
imide footprints). For both RPL34 and RPS15 no signifi-
cant change was detected at protein level with western blot
analysis, neither the presence of truncated isoforms (Sup-
plementary Figure S5). We attempted to validate the pres-
ence of dually decoded regions, N-terminally truncated or
extended isoforms and small ORFs derived from uORFs, in
a genomewide scale, by screening publicly available rawLC-
MS/MS proteomic datasets, including two C2C12-specific
datasets (77,78) and a HiRIEF LC-MS/MS deep proteome
dataset from N2A mouse cell (79). None of the novel can-
didate peptides passed our stringent spectrum-level valida-
tion, consistent with an extremely low abundance of these
peptides or detection of ribosome stalling (see ‘Discussion’
section).
DISCUSSION
Gene expression programs control tissue development and
regeneration. Whereas regulation of gene expression at
transcriptional level is extensively studied at genome-wide
level, control of mRNA translation has mostly been stud-
ied on individual genes. Polyribosomal mRNAs profiling
has been used in the past to obtain a global overview of
translation efficiency. However, the novel approach of ribo-
some footprint profiling enables translatome analysis at the
same level as transcriptome analysis. Nonetheless, the exist-
ing protocol for ribosome profiling is laborious and, to date,
there are no dedicated pipelines for the analysis of the short
ribosome footprints.
Here we describe a simplified protocol for ribosome pro-
filing and a novel data analysis pipeline, which includes a
combined mapping procedure for short reads, the analy-
sis of the triplet periodicity and a dynamic peak calling al-
gorithm to detect annotated and/or novel TISs, including
aORFs and uORFs in frame or out-of-frame compared to
the annotated ORF. We used our simplified protocol and
custom pipeline to investigate the extent of translational
control during the formation of mammalian skeletal mus-
cles, based on the analysis of the translatome, promoterome
and transcriptome of proliferating myoblasts and differen-
tiated myotubes in the murine C2C12 cell model. We inte-
grated ribosome profiling data, DeepCAGE data, RNAseq
and miRNAseq data to assess the contribution of transla-
tional regulation to the changes in protein expression dur-
ing myogenic differentiation.
Detection of TISs
To investigate the impact of alternative translation initia-
tion, we used our custom dynamic peak calling algorithm to
detect and quantify alternative TIS usage during differenti-
ation in harringtonin treated myoblasts and myotubes. Our
algorithm detected 5333 not yet annotated TISs, providing
an extensive catalog of alternative TISs leading to uORFs,
aORF and potentially dual coding regions, specifically used
during myogenesis.
We report only a high confidence set of TISs. Not all
peaks called from the harringtonin footprintsmay represent
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genuine TISs. False positive peaks may arise in the distal
part of the coding regions, when the harringtonin treatment
is too short for elongating ribosomes to finish the transla-
tion of the C-terminal part of the protein. For this reason
we developed a dynamic peak calling algorithm which con-
siders not only the triplet periodicity pattern, but also the
coverage and the relative position of each candidate TIS.
Alternative TISs detected in the 5′-UTRs (corresponding to
∼20% of mapped reads) showed a codon distribution simi-
lar to previously reported studies (24,25,55), with CUG and
GUG codons being the most abundant non-AUG codons,
whereas 50% of the footprints mapped to annotated start
codons. Overall, these findings give confidence in our data.
Likely, many more TIS are used during myogenesis, but
they were not abundant enough to be detected in our exper-
iments. We detected a lower number of TISs in myotubes
compared to myoblasts, which may relate to lower num-
bers of footprints prior to peak calling. Nevertheless, it does
not exclude the possibility that the lower percentage of al-
ternative TISs in myotubes reflects a true biological phe-
nomenon, considering that differentiated cells becomemore
specialized and therefore require a smaller protein reper-
toire.Wemay also have lost alternative TIS due to our strin-
gent thresholds: alternative TIS were only called when their
abundancewas at least 10%of the full length isoform, where
previous reports demonstrated that N-terminally truncated
protein isoforms present at only 5% of the full length iso-
form can exert biologically significant effects (10,80). How-
ever, we preferred to not decrease this threshold and avoid
false positives.
In our study ∼30% of the reads mapped within the cod-
ing regions of pORFs. Only∼6% of the TISs located in cod-
ing regions were in-frame with their pORFs (∼4% in case
of TISs detected in myotubes), representing potential pro-
tein isoforms with truncated N-termini. We were not able
to confirm the presence of alternative truncated protein iso-
forms forRPL34 andRPS15 at western blot level. An expla-
nation could be pausing of ribosomes during the harring-
tonine treatment, or leaky scanning of the pORF TIS that
results in recognition of a downstream start codon yielding
to an instable alternative isoforms. The primary ribosomal
proteins are stable and accumulate in the cell, whereas the
isoformdoes not accumulate. Regulation of protein stability
is another control mechanisms determining protein abun-
dance, which cannot be addressed by ribosome profiling.
The remaining TIS located in the coding regions where out-
of-frame TISs. A portion of it may represent potential dual
coding regions. Previous studies have detected dual coding
regions in genes involved in fundamental cellular processes
(21), such as translation (Eif4a2), cell cycle (Cdkn2a) and
protein degradation (Ube2e2). Many translation initiation
factors, including Eif1, Eif4a2, Eif4e2, Eif4a1, Eif2s1 and
Eif5 showed a switch in TIS usage during myoblasts dif-
ferentiation. We did not observe dual coding in Eif4a2 in
our data, but we did detect two TISs in Eif1, one represent-
ing the annotated start codon and the other representing an
out-of-frame aORF with an AUG start. Nevertheless, for
the majority of the alternative out-of-frame TISs, we cur-
rently lack further evidence. Our attempt to validate dual
coding regions, in-frame aORF and small peptides derived
fromuORFs, based on publicly availablemass spectrometry
data, present several limitations, even if the proteomic data
used is of high quality and acquired using state-of-the art in-
strumentation and methodology. An untargeted proteomic
approach is not ideal due to dynamic range limitations and
difficulties in detecting and quantifying low-abundant pro-
teins among a diverse pool (81). A recent study showed that
ribosome profiling data could be used to improve identifi-
cation of novel N-termini isoforms and translated upstream
ORF from proteomic data (82). However, only a small num-
ber of translated uORFs and N-terminal extensions was
validated. We therefore conclude that the lack of consis-
tency between ribosome profiling data and mass spectrom-
etry data does not invalidate our findings, but positive val-
idation of these translated uORFs and aORFs on protein
level may require enrichment of peptides by anti-peptide
antibodies raised against a number of predicted and syn-
thesized peptides.
In this study we restricted the detection of TISs in cod-
ing transcripts. Nevertheless, a percentage of footprints de-
rived from non-coding transcripts. LincRNAs bound to ri-
bosomes have been observed in previous ribosome profil-
ing (24) and polysome profiling studies (83). Whether they
lead to active translation is still debated, with some studies
showing no coding potential (84,85) and others suggesting
that translation occurs in portions of lincRNAs (61). The
fragment-size of the protected footprint is one of the pa-
rameters commonly used to distinguish true ribosome foot-
prints from RNA fragments derived from transcripts pro-
tected by other complexes that may co-sediment with ri-
bosomes or fragments derived from stable RNA secondary
structure. Our read-length distribution analysis showed that
lincRNAs did not always display a preference for one spe-
cific read-length, as protein coding genes did, and for those
which showed a preferential peak surrounding 30 nt, we
did not observe characteristic signatures of translation, not
even restricted to portions of the lincRNAs.
Cellular processes controlled by selective mRNA translation
in myogenesis
During differentiation of myoblasts into multinucleated
myotubes, protein synthesis generally correlated with
mRNA levels for the majority of the genes. Genes with
lower correlations are likely regulated at the level of mRNA
translation. The latter were strongly enriched for genes en-
coding for ribosomal proteins, whereas a modest enrich-
ment for genes involved in protein degradation, focal adhe-
sions, regulation of actin cytoskeleton and calcium signal-
ing was also observed. The ribosomal protein genes and the
calcium signaling pathway were also enriched in the set of
genes showing alternative TIS usage, but the enriched genes
were different, indicating that these pathways are mainly
regulated at translational level not only by different trans-
lation initiation but also through other mechanisms.
A previous study showed that the production of three ri-
bosomal proteins (S16, L18 and L32) is regulated both at
the level of transcription and translation during myoblast
differentiation (86). The authors showed a decrease in tran-
scription and a decrease in translation efficiency by mea-
suring mRNA bound to polysomes. In line with their study,
S16, L18 and L32 showed a significantly lower number of
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harringtonin footprints in myotubes, whereas the decrease
in cycloheximide footprints did not reach statistical sig-
nificance. A general downregulation was observed for the
majority of the ribosomal protein genes both at transcrip-
tional and translational level. Despite a positive correla-
tion between RNAseq and cycloheximide footprints (r =
0.79, Pearson correlation), we found a poor correlation be-
tween RNAseq data and harringtonin footprints (r = 0.27,
Pearson correlation), much lower than the correlation for
all genes (r = 0.65). This discrepancy observed may be ex-
plained in different ways, one of which could be ribosome
stalling, a known limitation in ribosome profiling data (87).
If elongating ribosomes are stalled, this may lead to accu-
mulation of footprints, which might be detected as alterna-
tive TISs in harringtonin data. The same applies to cyclo-
heximide footprints, where ribosomal pauses might inter-
fere with a correct quantification of translation. However,
even if the peaks and footprints do not always reflect the
production of novel short peptides or protein isoforms, we
observed significant changes in ribosome footprints at those
sites during myogenesis. These changes are highly repro-
ducible between replicates, they are cell specific and tightly
controlled during differentiation and therefore they likely
represent a regulatory mechanism with relevance for mus-
cle differentiation.
The mechanisms regulating alternative TISs usage in
myogenesis remain to be investigated. Previous studies have
shown that proteins involved in the translation machinery
are autoregulated (35) and their synthesis is mainly con-
trolled at the level of translation (88). These mRNAs are
mainly characterized by the presence of structural motifs,
such as the 5′ TOP. The mTOR signaling pathway is known
to regulate translation of TOP mRNAs. Serum removal
could represent a downregulating stimulus for the mTOR
pathway, possibly leading to mTOR-pathway inactivation
and mTOR-dependent translation repression. The proto-
col for C2C12 differentiation is based on serum reduction
(from 10 to 2% FBS) but our data does not show evidence
of a major contribution of the mTOR signaling pathway to-
ward the control of TOP mRNAs translation during myo-
genic differentiation, as we do not observe any enrichment
of transcripts bearing a 5′ TOP and affected by a switch in
TIS usage. Other studies have previously shown that the in-
hibition of mTOR can have different outcomes, from a ma-
jor effect to little or no effect on TOP mRNA translation,
depending on the cellular context (88). The ribosomal pro-
tein genes and translation factors which showed a switch in
TIS usage did not contain a 5′ TOP, therefore we suggest
that a different mechanism is used.
Next to genes involved in the translational apparatus, we
found that many of the genes showing a switch in TIS usage
are known to play a role in muscle development, mainte-
nance and regeneration. Cryab (63,64), Spp1 (66), Tmbim6
(71) and Cs (73) have been previously shown to be regu-
lated at transcriptional level during myogenic differentia-
tion.Eno3 (67,68),Pgam (69) andAgl (70) have been related
to metabolic myopathies, whereas Eno3 (74) and Spp1 (75)
have been recently reported as biomarkers formuscular dys-
trophies. We showed that these genes are regulated at trans-
lational level by switches of alternative TIS usage between
uORFs and pORFs during differentiation.Due to themany
regulatory potential of uORFs, a full understanding of the
translational control of these genes may be relevant for clin-
ical purposes.
The contribution of mRNA translation in myogenesis
Even though we observed a general positive correlation be-
tween transcription and translation, suggesting that most
of the regulation occurs at transcriptional level, we also ob-
served a dampening effect of translational regulation. The
causes of this dampening effect remain to be elucidated.
Translation can be regulated bymany differentmechanisms.
Here we specifically focused on the alternative use of start
codons. Our study showed that 312 genes were subjected to
switches in alternative TIS usage during differentiation. Al-
though we showed that the presence of a myotube-specific
promoter in Tpm3 resulted in an alternative TIS, we found
that the majority of the switches detected at translational
level was independent from transcription. Switches in TIS
usage mostly occurred in genes with a single promoter, thus
the transcription of genes from distinct promoters, and the
translation initiation from distinct start codons, seem to be
two complementary mechanisms to control gene and pro-
tein expression in myogenesis. Moreover, we showed that
alternative promoters may also lead to recognition of regu-
latory uORFs located in the 5′-UTR, as shown for Cryab.
Therefore, alternative TSS can be used to regulate protein
levels. Nevertheless the detection of alternative TSSsmay be
challenging when TSSs are characterized by a broad peak
(59). The DeepCAGE technology and the subsequent clus-
tering procedure may not have the resolution to identify
TSSs which are in close proximity, leading to the incorpo-
ration of alternative TSSs into one single TSS. Our analy-
sis might therefore underestimate the number of alternative
TSSs which are in very close proximity and therefore overes-
timate the number of switches in TIS usage exclusively de-
pendent on the translational control. It remains to be in-
vestigated to which extent this phenomenon may alter our
results.
A considerable amount of footprint mapped in the 5′-
UTRs. Even though it is difficult to predict the effect of an
uORF based on the length, many reports suggest that short
uORFs are regulatory, whereas long uORFs and out-of-
frame uORFs overlapping the pORF primarily inhibit pro-
tein synthesis (89,90). We showed that the majority of the
non-overlapping uORFs were between 1–30 amino acids
long, whereas the majority of the overlapping uORFs were
longer than 30 amino acids, suggesting a likely stronger reg-
ulatory potential.
We further investigated the contribution of miRNAs in
the regulation of translation, focusing onwell-characterized
myomiRs. For all experimentally validated targets we did
not observe any major effect on translation inhibition. The
amount of mRNAs targets present at transcriptome level
and the amount of mRNAs targets translated reflected the
general dampening effect observed for all other non-target
genes, indicating that the myimiRs do not primarily affect
the translational control of their target mRNAs.
In conclusion, our results demonstrate that translation
initiation represent a layer of regulation of protein expres-
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sion in myogenesis for specific subsets of functionally cor-
related genes.
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